Strategic Partnerships Bluegrass Vascular has a history of collaboration, including a strategic relationship with Merit Medical Systems. This indicates a receptiveness to channel partners and potential distributors or OEM collaborations to expand market reach for the Surfacer system.

Clinical Trial Footprint With the SURFacer System for Venous Occlusions in pivotal trials and ongoing SAVE clinical program, there are opportunities to engage hospitals and vascular centers participating in or expanding these trials, presenting a path to early-adopter institutions and key opinion leaders.

Executive Growth Recent addition of a Vice President of Sales signals formalization of commercial strategy and scaling plans. This creates an opening to approach the leadership team with value propositions aligned to growth, training, and field deployment support.

Targeted Medical Devices As a niche medical device company addressing central venous access, opportunities exist to cross-sell or bundle Surfacer with accessory sterile systems, training programs, and procedural support services to vascular labs and interventional suites.

Funding & Milestones With current funding and modest revenue, there is a window for grantee and early-adopter hospitals to participate in pilot programs or sponsored trials, enabling phased deployments and evidence generation to drive broader adoption.